Cargando…
Timing Determination of Invasive Fungal Infection Prophylaxis According to Immune Function in HSCT Patients
Patients who receive a hematopoietic stem cell transplantation (HSCT) exhibit an immune defect after recovering from neutropenia. The current guidelines do not recommend fungal prophylaxis in these patients, except for grades III to IV GVHD in HSCT. Thus, the timing for the initiation and cessation...
Autores principales: | Ma, Jiexian, Hu, Yingwei, Wu, Min, Wang, Xiaoqin, Xie, Yanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840169/ https://www.ncbi.nlm.nih.gov/pubmed/29552004 http://dx.doi.org/10.3389/fmicb.2018.00370 |
Ejemplares similares
-
(18)F-fluorodeoxyglucose positron emission tomography—based prediction for splenectomy in patients with suspected splenic lymphoma
por: Hu, Yingwei, et al.
Publicado: (2021) -
Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis
por: Yang, Apeng, et al.
Publicado: (2019) -
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study
por: Maziarz, Richard T., et al.
Publicado: (2016) -
Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study
por: Li, Weiyang, et al.
Publicado: (2020) -
Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens
por: Valero, Clara, et al.
Publicado: (2016)